These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 21545853

  • 1. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M, Itoh K.
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [Abstract] [Full Text] [Related]

  • 2. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM, Brennan VC, Gutierrez NM, Wang X, Wang L, Yang WH.
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [Abstract] [Full Text] [Related]

  • 3. Activity-Induced SUMOylation of Neuronal Nitric Oxide Synthase Is Associated with Plasticity of Synaptic Transmission and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Du CP, Wang M, Geng C, Hu B, Meng L, Xu Y, Cheng B, Wang N, Zhu QJ, Hou XY.
    Antioxid Redox Signal; 2020 Jan 01; 32(1):18-34. PubMed ID: 31642335
    [Abstract] [Full Text] [Related]

  • 4. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH, Lussier-Price M, Cappadocia L, Estephan P, Raiola L, Omichinski JG, Aubry M.
    J Biol Chem; 2013 Dec 20; 288(51):36312-27. PubMed ID: 24174529
    [Abstract] [Full Text] [Related]

  • 5. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K, Lee TD, Chen Y.
    J Biol Chem; 2012 May 04; 287(19):15154-63. PubMed ID: 22403398
    [Abstract] [Full Text] [Related]

  • 6. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL, Hsiao HH, Yeh YY, Shia HL, Chen YL, Liang PH, Wang AH, Khoo KH, Shoei-Lung Li S.
    J Biol Chem; 2004 Sep 17; 279(38):39653-62. PubMed ID: 15272016
    [Abstract] [Full Text] [Related]

  • 7. Modulation of inducible nitric oxide synthase expression by sumoylation.
    Akar CA, Feinstein DL.
    J Neuroinflammation; 2009 Mar 26; 6():12. PubMed ID: 19323834
    [Abstract] [Full Text] [Related]

  • 8. Distinct functional modes of SUMOylation for retinoid X receptor alpha.
    Lee WP, Jena S, Rodriguez EP, O'Donovan SP, Wagner C, Jurutka PW, Thompson PD.
    Biochem Biophys Res Commun; 2015 Aug 14; 464(1):195-200. PubMed ID: 26116533
    [Abstract] [Full Text] [Related]

  • 9. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N, Chaugule VK, Pichler A.
    Methods Mol Biol; 2016 Aug 14; 1475():67-78. PubMed ID: 27631798
    [Abstract] [Full Text] [Related]

  • 10. Sumoylation of CoREST modulates its function as a transcriptional repressor.
    Muraoka A, Maeda A, Nakahara N, Yokota M, Nishida T, Maruyama T, Ohshima T.
    Biochem Biophys Res Commun; 2008 Dec 26; 377(4):1031-5. PubMed ID: 18854179
    [Abstract] [Full Text] [Related]

  • 11. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U, Jääskeläinen T, Rytinki M, Kaikkonen S, Palvimo JJ.
    J Mol Biol; 2008 Oct 10; 382(3):585-600. PubMed ID: 18656483
    [Abstract] [Full Text] [Related]

  • 12. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT, Fitzgerald ME, Maiti A, Reiter KH, Guzzo CM, Matunis MJ, Drohat AC.
    J Biol Chem; 2014 May 30; 289(22):15810-9. PubMed ID: 24753249
    [Abstract] [Full Text] [Related]

  • 13. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA, Lima CD.
    Methods Enzymol; 2005 May 30; 398():74-87. PubMed ID: 16275321
    [Abstract] [Full Text] [Related]

  • 14. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E, Schröder-Kress N, Sticht H, Enz R.
    Biochem J; 2011 Apr 15; 435(2):365-71. PubMed ID: 21288202
    [Abstract] [Full Text] [Related]

  • 15. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH, Kim S, Yu B, Jaffray E, Song J, Zheng J, Rodriguez MS, Hay RT, Chen Y.
    Biochemistry; 2003 Aug 26; 42(33):9959-69. PubMed ID: 12924945
    [Abstract] [Full Text] [Related]

  • 16. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D, Müller S.
    Proc Natl Acad Sci U S A; 2002 Mar 05; 99(5):2872-7. PubMed ID: 11867732
    [Abstract] [Full Text] [Related]

  • 17. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L.
    Mol Endocrinol; 2005 Nov 05; 19(11):2671-84. PubMed ID: 15961505
    [Abstract] [Full Text] [Related]

  • 18. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS, Campbell M, Kung HJ, Chang PC.
    J Vis Exp; 2018 Jan 29; (131):. PubMed ID: 29443041
    [Abstract] [Full Text] [Related]

  • 19. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
    Dustrude ET, Wilson SM, Ju W, Xiao Y, Khanna R.
    J Biol Chem; 2013 Aug 23; 288(34):24316-31. PubMed ID: 23836888
    [Abstract] [Full Text] [Related]

  • 20. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y, Sankpal UT, Robertson AK, McNally JG, Karpova T, Robertson KD.
    Nucleic Acids Res; 2004 Aug 23; 32(2):598-610. PubMed ID: 14752048
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.